This article refers to:
Criscitiello C, Viale G, Curigliano G, et al. Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date. Breast Cancer (Dove Med Press). 2018;10:23–29.
On page 23, Giuseppe Curigliano’s affiliation was incorrcectly listed as European Institute of Oncology, Milan, Italy. It should be Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapy, University of Milan, European Institute of Oncology, Milan, Italy.